Skip to main content

Live Webinar - Cardiac PET Imaging: What's new and how to start?

-

Thursday, October 22, 2020 - 6:53

<p><span><span><span><span><span><span><span>As our healthcare systems is constantly looking for more value medicine, the use of cardiac PET is rapidly expanding and becoming one of the pillar for cardiac imaging. Cardiac PET has been widely adopted because it provides : high diagnostic accuracy and it is safe, efficient and patient-centered.</span></span></span></span> </span></span></span></p> <p><span><span><span>IBA invites you to attend a free webinar presented by 2 leading figures of Nuclear Medicine: Dr. Terrence Ruddy and Dr Parthiban Arumugam.</span></span></span></p> <p><strong><span><span><span>When?</span></span></span></strong><span><span><span>&nbsp;November 12<sup>th</sup>, 3 - 4 pm CET (9-10 am EST)</span></span></span></p> <p><a href="https://us02web.zoom.us/webinar/register/9716033506184/WN_6ZB_TbMsSXedbk8SOHE4Vg"><span><span><span>Register here</span></span></span></a></p> <p><br /> <span><span><span><strong><span><span><span><span>What will you learn from the webinar ?</span></span></span></span></strong> </span></span></span></p> <ul> <li><strong><span><span><span><span><span><span><span><span><span>Cardiac PET Myocardial Perfusion Imaging in 2020 &nbsp;</span></span></span></span></span></span></span></span></span></strong></li> </ul> <p><span><span>&nbsp;</span></span><span><span><span><span><span><span><span>Dr Ruddy will start with the basic of PET Cardiac imaging versus other modalities and share the recent advances in the field including the last results of the ISCHEMIA trial and coming CMS AUC (Appropriate User criteria) and its potential impact in the field.<br /> <br /> Dr. Terrence Ruddy, FRCPC,FACC is the Director of Nuclear Cardiology at University of Ottawa Heart Institute and a Professor of Medicine and Radiology at the University of Ottawa.</span></span></span></span><br /> <br /> &nbsp; </span></span></span></p> <ul> <li><strong><span><span>&nbsp;</span></span><span><span><span><span><span><span><span><span><span>How to implement a Cardiac PET Program in your site?</span></span></span></span></span></span></span></span></span></strong></li> </ul> <p><span><span>&nbsp;</span></span><span><span><span><span><span><span><span>Dr Arumugam will share his expertise on how to plan and implement a PET Cardiac Imaging Program covering resources (cost of equipment, tracers and staffing requirements) and supporting guidelines from national and international societies and also additional information that perfusion PET can offer over and above SPECT for a more precise diagnosis.<br /> <br /> Dr Parthiban Arumugam is a Consultant Nuclear Medicine Physician at Manchester University NHS Foundation Trust in the United Kingdom Society.</span></span></span></span> </span></span></span></p> <p><a href="https://us02web.zoom.us/webinar/register/9716033506184/WN_6ZB_TbMsSXedbk8SOHE4Vg"><span><span><span>Register here</span></span></span></a></p>
Share

More news

-

IBA SELECTED TO EQUIP WEST CHINA MEDICAL CENTER

West China Medical of Sichuan University located in Chengdu, Sichuan, China has commissioned IBA to install a particle accelerator to produce radioisotopes for cancer&nbsp;diagnosis &nbsp; Louvain-la-Neuve, Belgium, November 25th 2020 - IBA (Ion Beam Applications S.A., EURONEXT), the world's leading provider of solutions for the diagnosis and treatment of cancer, and West China Medical center, the largest single-site hospital in the world consistently ranked in the top three hospitals in China, announce today that they have signed a contract for the installation of a 18 MeV cyclotron. The Cyclone® KIUBE is a cyclotron used to produce radiopharmaceuticals dedicated to Positron emission tomography (PET), a modern cancer diagnostic method. “PET imaging procedures play a critical role in medical care today and growing demand for radioisotopes in China means a greater need for efficiency.” Said Mr. Chen Li, Sales Director of IBA RadioPharma Solutions China. “The Cyclone KIUBE is more compact and powerful. It was developed with three keywords in mind, Reliability, High Performance and Flexibility.” Bruno Scutnaire, President of IBA's RadioPharma Solutions Business line said: "We are pleased that West China Medical Center has selected our Cyclone® KIUBE. For over 35 years, IBA has installed more than 600 particle accelerators worldwide, proving the excellent reliability of our systems.” The Cyclone® KIUBE is Upgradable like no other cyclotron, West China Medical Center will be able to increase its production capacity step-by-step over time if needed, to reach&nbsp;up to 300 µA on target. The cyclotron will be ready for production of Ga-68, Cu-64 and Cu-61 with the IBA Nirta® liquid target. &nbsp;
See more